ATE347369T1 - Verfahren zur stimulierung des wachstums und des widerstands gegen erkrankungen von wasserorganismen - Google Patents

Verfahren zur stimulierung des wachstums und des widerstands gegen erkrankungen von wasserorganismen

Info

Publication number
ATE347369T1
ATE347369T1 AT03744706T AT03744706T ATE347369T1 AT E347369 T1 ATE347369 T1 AT E347369T1 AT 03744706 T AT03744706 T AT 03744706T AT 03744706 T AT03744706 T AT 03744706T AT E347369 T1 ATE347369 T1 AT E347369T1
Authority
AT
Austria
Prior art keywords
diseases
resistance
aquatic organisms
stimulating growth
stimulating
Prior art date
Application number
AT03744706T
Other languages
English (en)
Inventor
Garcia Mario Pablo Ave Estrada
Rodriguez Rebeca Ave Martinez
Cruz Amilcar Circunvala Arenal
Perez Rafael Marcos C Pimentel
Vazquez Alexander Espinosa
Molina Carmen Aday Circ Garcia
Gonzalez Edenaida Circ Cabrera
Campa Mirta C Alegria E Vinjoy
Perez Sergio Toledo
Farnes Olimpia Carrillo
Munoz Claudina Zaldivar
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE347369T1 publication Critical patent/ATE347369T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Peptides Or Proteins (AREA)
AT03744706T 2002-01-24 2003-01-22 Verfahren zur stimulierung des wachstums und des widerstands gegen erkrankungen von wasserorganismen ATE347369T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU2002002020020020A CU23016A1 (es) 2002-01-24 2002-01-24 Método para la estimulación del crecimiento y resimétodo para la estimulación del crecimiento y resistencia a enfermedades en organismos acuáticos y fstencia a enfermedades en organismos acuáticos y formulación veterinaria ormulación veterinaria

Publications (1)

Publication Number Publication Date
ATE347369T1 true ATE347369T1 (de) 2006-12-15

Family

ID=28050593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03744706T ATE347369T1 (de) 2002-01-24 2003-01-22 Verfahren zur stimulierung des wachstums und des widerstands gegen erkrankungen von wasserorganismen

Country Status (17)

Country Link
US (1) US8852601B2 (de)
EP (1) EP1477181B1 (de)
JP (1) JP4195865B2 (de)
KR (1) KR100953778B1 (de)
CN (1) CN1622821B (de)
AR (1) AR038310A1 (de)
AT (1) ATE347369T1 (de)
AU (1) AU2003210124A1 (de)
BR (2) BRPI0307092B1 (de)
CA (1) CA2473973C (de)
CU (1) CU23016A1 (de)
DE (1) DE60310203D1 (de)
DK (1) DK1477181T3 (de)
EC (1) ECSP045186A (de)
ES (1) ES2277097T3 (de)
MX (1) MXPA04006940A (de)
WO (1) WO2003080102A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050114004A (ko) * 2004-05-31 2005-12-05 (주)진투프로테인 재조합 소 성장 호르몬을 이용한 새우의 면역증강 및 성장촉진 방법
CU23557A1 (es) * 2005-11-22 2010-07-20 Ct Ingenieria Genetica Biotech Neuropéptidos para el cultivo de organismos acuáticos
CU23634A1 (es) * 2007-05-31 2011-02-24 Ct Ingenieria Genetica Biotech Secuencias de ácido nucleico y aminoácidos, y vacuna para el control de infestaciones por ectoparásitos en peces
TWI398219B (zh) * 2009-12-10 2013-06-11 Univ Nat Pingtung Sci & Tech 一種藻酸鈉用於提升對蝦屬生殖能力之用途
CU24473B1 (es) 2016-11-01 2020-02-04 Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411890A (en) * 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
US5486505A (en) * 1990-07-24 1996-01-23 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
EP0650597A4 (de) * 1992-06-29 1996-12-18 Univ South Florida Diagnostisches verfahren zur bewertung der ätiologie des minderwuchse.
EP0761220A1 (de) * 1995-08-21 1997-03-12 Eli Lilly And Company 2-Acylaminopropanamide zur Förderung der Wachstumshormon-Sekretion
US5767124A (en) * 1995-10-27 1998-06-16 Merck & Co., Inc. Polymorphic forms of a growth hormone secretagogue
US5972895A (en) * 1996-12-11 1999-10-26 A. Glenn Braswell Composition and method for increasing growth hormone levels
DE19828924C1 (de) * 1998-06-29 1999-06-02 Siemens Ag Schaltungsanordnung zum Steuern eines Fahrwerks- oder Antriebssystems in einem Kraftfahrzeug

Also Published As

Publication number Publication date
JP4195865B2 (ja) 2008-12-17
CN1622821B (zh) 2012-10-10
ES2277097T3 (es) 2007-07-01
US20060234905A1 (en) 2006-10-19
DE60310203D1 (de) 2007-01-18
MXPA04006940A (es) 2004-12-06
BRPI0307092B1 (pt) 2018-11-21
US8852601B2 (en) 2014-10-07
CA2473973C (en) 2011-01-04
EP1477181A1 (de) 2004-11-17
KR20040094676A (ko) 2004-11-10
AR038310A1 (es) 2005-01-12
AU2003210124A1 (en) 2003-10-08
CN1622821A (zh) 2005-06-01
DK1477181T3 (da) 2007-04-10
CA2473973A1 (en) 2003-10-02
BR0307092A (pt) 2004-12-28
ECSP045186A (es) 2004-08-27
JP2005519972A (ja) 2005-07-07
EP1477181B1 (de) 2006-12-06
CU23016A1 (es) 2005-01-25
WO2003080102A1 (es) 2003-10-02
KR100953778B1 (ko) 2010-04-21

Similar Documents

Publication Publication Date Title
DE602004022061D1 (de) Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen
ATE389649T1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
EP1701654A4 (de) Implantierbarer biosensor und anwendungsverfahren
DE602004000224D1 (de) Medizinisches Adsorbent und Verfahren zur Herstellung
ATE490964T1 (de) Pyrrolopyridazin-verbindungen und verwendungsverfahren dafür zur behandlung von proliferativen erkrankungen
EP1896083A4 (de) Verfahren zur behandlung von pompe-krankheit mit 1-desoxynojirimycin und derivaten
EP1540698A4 (de) System und verfahren zur herstellung von arrays biologischer oder anderer molek le
EP1948799A4 (de) Verwendung von bakteriocinen zur förderung von pflanzenwachstum und krankheitsresistenz
DE60319772D1 (de) Verwendung und Methode zur Haarfärbung
AU2003268531A8 (en) Materials and methods for treatment of allergic diseases
ATE451915T1 (de) Vorrichtung zur verlängerten freisetzung und methode zur okularen verabreichung von carboanhydrase inhibitoren
DE602005015415D1 (de) N ausgewählter n-3-fettsäuren zur behandlung von erkrankungen des zentralen nervensystems
EP1635801A4 (de) Verfahren zur behandlung und prävention von herzarrhythmie
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
DE602004001134D1 (de) Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit
DE60317676D1 (de) Methode zur zielgerichteten stimulation der meiotischen rekombination und reagentensätze um diese methode auszuführen
DE112004002647D2 (de) Verfahren und Vorrichtung zur Stimulation von Funktionen zur Steuerung von Betriebsabläufen
DE60327856D1 (de) Zusammensetzungen und verfahren zur hautbräunung
EP1651237A4 (de) Verfahren zur behandlung von dermatologischen erkrankungen
FR2878532B1 (fr) Methode d'adressage d'acides nucleiques vers des plastes
EP1592464A4 (de) Verfahren zur behandlung von kognitivem verfall aufgrund von schlafmangel und stress
ATE347369T1 (de) Verfahren zur stimulierung des wachstums und des widerstands gegen erkrankungen von wasserorganismen
DE60308375D1 (de) Fischgelatinekapsel und Verfahren zur Herstellung
DE60301584D1 (de) Vernetzbare Fluorkautschukzusammensetzungen und Verfahren zur Herstellung
ATE418337T1 (de) Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties